Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion type Assertion NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_head.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion description "[The estimated relative risk was significantly high for individuals with w1/m1 genotype at 3'UTR of CYP1A1 gene (OR-4.64; 95%CI = 1.51-14.86; P < 0.01) whereas the CYP1A1 Ile/Val genotype (w2/m2) on exon 7 was found to be associated with a decreased risk for prostate cancer (OR-0.17; 95%CI = 0.02-0.89; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_provenance.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion evidence source_evidence_literature NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_provenance.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion SIO_000772 17192049 NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_provenance.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion wasDerivedFrom befree-2016 NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_provenance.
- NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_assertion wasGeneratedBy ECO_0000203 NP586217.RARo0RVLsF6cLU_wB4kVY-MGa_EkrY2MqbToxtbYJvN_Y130_provenance.